Evidence map›Paper›PMID 22666537›Full record

ArticleScientific reports2012

EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours.

Olga Bornachea, Mirentxu Santos, Ana Belén Martínez-Cruz, Ramón García-Escudero, Marta Dueñas, Clotilde Costa, Carmen Segrelles, Corina Lorz, Agueda Buitrago, Cristina Saiz-Ladera and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2021
    Article
  10. Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Article
  13. EMT signaling: potential contribution of CRISPR/Cas gene editing.Cellular and molecular life sciences : CMLS · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Olga BornacheaMolecular Oncology Unit, CIEMAT, Ave. Complutense 40, E-28040 Madrid, Spain.
Mirentxu Santos
Ana Belén Martínez-Cruz
Ramón García-Escudero
Marta Dueñas
Clotilde Costa
Carmen Segrelles
Corina Lorz
Agueda Buitrago
Cristina Saiz-Ladera
Xabier Agirre
Teresa Grande
Beatriz Paradela
Antonio Maraver
José M Ariza
Felipe Prosper
Manuel Serrano
Montse Sánchez-Céspedes
Jesús M Paramio
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESUniversidad Complutense de Madrid · ESCentro de Investigación del Cáncer · ESUniversidad de Navarra · ESDuran i Reynals Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Missense mutations in TP53 gene promote metastasis in human tumours. However, little is known about the complete loss of function of p53 in tumour metastasis. Here we show that squamous cell carcinomas generated by the specific ablation of Trp53 gene in mouse epidermis are highly metastatic. Biochemical and genome-wide mRNA and miRNA analyses demonstrated that metastases are associated with the early induction of epithelial-mesenchymal transition (EMT) and deregulated miRNA expression in primary tumours. Increased expression of miR-21 was observed in undifferentiated, prometastatic mouse tumours and in human tumours characterized by p53 mutations and distant metastasis. The augmented expression of miR-21, mediated by active mTOR and Stat3 signalling, conferred increased invasive properties to mouse keratinocytes in vitro and in vivo, whereas blockade of miR-21 in a metastatic spindle cell line inhibits metastasis development. Collectively these data identify novel molecular mechanisms leading to metastasis in vivo originated by p53 loss in epithelia.

Indexed as

AnimalsBlotting, WesternCarcinoma, Squamous CellCell LineCells, CulturedEpidermisEpithelial-Mesenchymal TransitionGene Expression ProfilingGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateKeratinocytesLung NeoplasmsMiceMicroRNAsMutationMicroRNAsMIRN21 microRNA, humanMIRN21 microRNA, mouseSTAT3 Transcription FactorTOR Serine-Threonine KinasesTumor Suppressor Protein p53

Identifiers

PMID22666537
PMCPMC3364492
OpenAlexW2166282686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.